Epigenetic regulations of inflammatory cyclooxygenase-derived prostanoids: molecular basis and pathophysiological

Hedi Harizi1

  • 1Faculty of Dental Medicine, University of Monastir, 5000 Monastir, Tunisia.

Insights

Epigenetic modifications regulate prostanoid signaling in immune responses and inflammatory diseases. Understanding these epigenetic changes in cyclooxygenase (COX) pathways offers potential for new therapeutic strategies.

Area of Science:

  • Immunology and molecular biology, focusing on prostanoid signaling pathways.

Background:

  • Prostanoid signaling, particularly from Cyclooxygenase (COX) enzymes, is implicated in various immunoinflammatory disorders like asthma, rheumatoid arthritis, cancer, and autoimmune diseases.
  • Epigenetic mechanisms add complexity to prostanoid biology, influencing biosynthesis and receptor signaling, and are crucial for regulating COX pathways.

Purpose of the Study:

  • To investigate the role of epigenetic modifications in the regulation of inflammatory prostanoids during physiological immune responses and in immunological disorders.
  • To elucidate how epigenetic regulation impacts prostanoid and receptor function and their contribution to inflammatory disease pathogenesis.

Main Methods:

  • Review and analysis of existing literature on epigenetic modifications affecting prostanoid biosynthesis and signaling pathways.
  • Focus on specific epigenetic alterations impacting inflammatory prostanoids and their receptors in the context of immune function and disease.

Main Results:

  • Epigenetic alterations are identified as key regulators of inflammatory prostanoid pathways.
  • These modifications influence the function of major prostanoids and their receptors, impacting disease processes.
  • Epigenetic control is crucial in the development of inflammatory diseases and potentially in neoplasia.

Conclusions:

  • Epigenetic regulation of inflammatory prostanoids is a significant factor in immune homeostasis and disease pathogenesis.
  • Understanding these epigenetic mechanisms provides insights into the development of novel therapeutic approaches for inflammatory and immunological disorders.

Related Concept Videos

Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
19.6K
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.8K
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents01:20

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
1.6K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
5.2K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
8.4K
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
1.6K